申请人:Biochem Pharma, Inc.
公开号:US06630488B1
公开(公告)日:2003-10-07
The present invention is directed towards novel compounds that are effective inhibitors of integrins, particularly &agr;IIb&bgr;3 or &agr;v integrins such as &agr;v&bgr;3 and &agr;v&bgr;5. One embodiment of the present invention comprises a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt, solvate, or metabolic precursor thereof. R1, R2, R3, and R4 are defined herein.
本发明涉及一种新型化合物,它们是有效的整合素抑制剂,特别是αIIbβ3或αv整合素,如αvβ3和αvβ5。本发明的一个实施例包括式(I)或式(II)的化合物,或其药学上可接受的盐、溶剂或代谢前体。R1、R2、R3和R4在此处被定义。